Loading organizations...
Key people at Dermapharm.
Dermapharm was founded in 1991 by Willi Beier (Founder).
Dermapharm manufactures and distributes branded pharmaceuticals and diverse healthcare products. Its integrated business model includes in-house development, manufacturing, quality control, and direct sales distribution. The company specializes in patent-free branded pharmaceuticals for specific therapeutic areas, complemented by specialized healthcare offerings.
Wilhelm Beier founded Dermapharm in 1991, leveraging pharmaceutical industry leadership. His insight addressed demand for established, effective branded pharmaceuticals that were off-patent. This enabled an accessible portfolio build, utilizing his profound industry knowledge for strategic growth and market penetration.
Dermapharm's products serve healthcare professionals and consumers across wellness and therapeutic segments. Its vision involves optimizing operations via strategic research, targeted acquisitions, and international expansion. The company pursues external growth alongside organic development, aiming for leadership as a high-growth manufacturer in niche markets.
Dermapharm was founded in 1991 by Willi Beier (Founder).
Key people at Dermapharm.
Dermapharm has 2 tracked investments across 1 company. The latest tracked deal is $20.0M Series B Extension in Wellster Healthtech Group in January 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 18, 2022 | Wellster Healthtech Group | $20.0M Series B Extension | Claret Capital Partners, Hans Jurgen Schmitz | HV Capital, Sevenventures |
| Jun 21, 2021 | Wellster Healthtech Group | $40.0M Other Equity | Dermapharm | Nawid ALI Abbassi, Sevenventures |
